Geron reported $640.9M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Amgen USD 541M 1000K Jun/2026
Bio Techne USD 156.45M 703K Mar/2026
Cassava Sciences USD 48.31M 0 Mar/2026
Cytokinetics USD 124.43M 2.17M Mar/2026
Exelixis USD 248.88M 4.82M Jun/2026
Genmab DKK 61.44M 181K Jun/2026
Geron USD 640.9M 2.54M Mar/2026
Gilead Sciences USD 1.24B 1000K Jun/2026
Incyte USD 200.98M 1.03M Jun/2026
MacroGenics USD 63.56M 241K Mar/2026
Novartis USD 1.9B 7.38M Jun/2026
Novavax USD 162.58M 106K Dec/2025